{
  "ticker": "REGN",
  "year": 2024,
  "quarter": 3,
  "last_updated": "2025-04-19T09:36:19.551340",
  "count": 125,
  "transactions": [
    {
      "id": 136677,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-04",
      "transaction_shares": "1200",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "26272"
    },
    {
      "id": 164821,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-04",
      "transaction_shares": "1200",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "26272"
    },
    {
      "id": 195425,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-04",
      "transaction_shares": "1200",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "26272"
    },
    {
      "id": 228316,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-04",
      "transaction_shares": "1200",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "26272"
    },
    {
      "id": 263932,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-04",
      "transaction_shares": "1200",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "26272"
    },
    {
      "id": 305200,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-04",
      "transaction_shares": "1200",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "26272"
    },
    {
      "id": 136664,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-09-03",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 136671,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-03",
      "transaction_shares": "4",
      "transaction_price": "1166.52",
      "transaction_type": "S",
      "shares_after_transaction": "17778"
    },
    {
      "id": 164808,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-09-03",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 164815,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-03",
      "transaction_shares": "4",
      "transaction_price": "1166.52",
      "transaction_type": "S",
      "shares_after_transaction": "17778"
    },
    {
      "id": 195412,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-09-03",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 195419,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-03",
      "transaction_shares": "4",
      "transaction_price": "1166.52",
      "transaction_type": "S",
      "shares_after_transaction": "17778"
    },
    {
      "id": 228300,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-09-03",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 228308,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-03",
      "transaction_shares": "4",
      "transaction_price": "1166.52",
      "transaction_type": "S",
      "shares_after_transaction": "17778"
    },
    {
      "id": 263914,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-09-03",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 263922,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-03",
      "transaction_shares": "4",
      "transaction_price": "1166.52",
      "transaction_type": "S",
      "shares_after_transaction": "17778"
    },
    {
      "id": 305182,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-09-03",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 305190,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-03",
      "transaction_shares": "4",
      "transaction_price": "1166.52",
      "transaction_type": "S",
      "shares_after_transaction": "17778"
    },
    {
      "id": 136663,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-08-28",
      "transaction_shares": "228",
      "transaction_price": "1204.79",
      "transaction_type": "S",
      "shares_after_transaction": "966"
    },
    {
      "id": 164807,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-08-28",
      "transaction_shares": "228",
      "transaction_price": "1204.79",
      "transaction_type": "S",
      "shares_after_transaction": "966"
    },
    {
      "id": 195411,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-08-28",
      "transaction_shares": "228",
      "transaction_price": "1204.79",
      "transaction_type": "S",
      "shares_after_transaction": "966"
    },
    {
      "id": 228299,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-08-28",
      "transaction_shares": "228",
      "transaction_price": "1204.79",
      "transaction_type": "S",
      "shares_after_transaction": "966"
    },
    {
      "id": 263913,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-08-28",
      "transaction_shares": "228",
      "transaction_price": "1204.79",
      "transaction_type": "S",
      "shares_after_transaction": "966"
    },
    {
      "id": 305181,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-08-28",
      "transaction_shares": "228",
      "transaction_price": "1204.79",
      "transaction_type": "S",
      "shares_after_transaction": "966"
    },
    {
      "id": 110503,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "10838",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "13010"
    },
    {
      "id": 110551,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 136653,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "10838",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "13010"
    },
    {
      "id": 136705,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 164797,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "10838",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "13010"
    },
    {
      "id": 164849,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 195400,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "10838",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "13010"
    },
    {
      "id": 195454,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 228287,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "10838",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "13010"
    },
    {
      "id": 228347,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 263900,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "10838",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "13010"
    },
    {
      "id": 263968,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 305168,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "10838",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "13010"
    },
    {
      "id": 305236,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 110533,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-13",
      "transaction_shares": "500",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "49599"
    },
    {
      "id": 110542,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-08-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 136687,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-13",
      "transaction_shares": "500",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "49599"
    },
    {
      "id": 136696,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-08-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 164831,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-13",
      "transaction_shares": "500",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "49599"
    },
    {
      "id": 164840,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-08-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 195435,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-13",
      "transaction_shares": "500",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "49599"
    },
    {
      "id": 195444,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-08-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 228327,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-13",
      "transaction_shares": "500",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "49599"
    },
    {
      "id": 228337,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-08-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 263946,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-13",
      "transaction_shares": "500",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "49599"
    },
    {
      "id": 263956,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-08-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 305214,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-13",
      "transaction_shares": "500",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "49599"
    },
    {
      "id": 305224,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-08-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 110529,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-08",
      "transaction_shares": "100",
      "transaction_price": "1081.83",
      "transaction_type": "S",
      "shares_after_transaction": "56096"
    },
    {
      "id": 136683,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-08",
      "transaction_shares": "100",
      "transaction_price": "1081.83",
      "transaction_type": "S",
      "shares_after_transaction": "56096"
    },
    {
      "id": 164827,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-08",
      "transaction_shares": "100",
      "transaction_price": "1081.83",
      "transaction_type": "S",
      "shares_after_transaction": "56096"
    },
    {
      "id": 195431,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-08",
      "transaction_shares": "100",
      "transaction_price": "1081.83",
      "transaction_type": "S",
      "shares_after_transaction": "56096"
    },
    {
      "id": 228323,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-08",
      "transaction_shares": "100",
      "transaction_price": "1081.83",
      "transaction_type": "S",
      "shares_after_transaction": "56096"
    },
    {
      "id": 263940,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-08",
      "transaction_shares": "100",
      "transaction_price": "1081.83",
      "transaction_type": "S",
      "shares_after_transaction": "56096"
    },
    {
      "id": 305208,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-08",
      "transaction_shares": "100",
      "transaction_price": "1081.83",
      "transaction_type": "S",
      "shares_after_transaction": "56096"
    },
    {
      "id": 110530,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2024-08-07",
      "transaction_shares": "487",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "4691"
    },
    {
      "id": 136684,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2024-08-07",
      "transaction_shares": "487",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "4691"
    },
    {
      "id": 164828,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2024-08-07",
      "transaction_shares": "487",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "4691"
    },
    {
      "id": 195432,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2024-08-07",
      "transaction_shares": "487",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "4691"
    },
    {
      "id": 228324,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2024-08-07",
      "transaction_shares": "487",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "4691"
    },
    {
      "id": 263941,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2024-08-07",
      "transaction_shares": "487",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "4691"
    },
    {
      "id": 305209,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2024-08-07",
      "transaction_shares": "487",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "4691"
    },
    {
      "id": 110506,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-02",
      "transaction_shares": "23638",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "74637"
    },
    {
      "id": 110508,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-02",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 136656,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-02",
      "transaction_shares": "23638",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "74637"
    },
    {
      "id": 136658,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-02",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 164800,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-02",
      "transaction_shares": "23638",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "74637"
    },
    {
      "id": 164802,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-02",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 195403,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-02",
      "transaction_shares": "23638",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "74637"
    },
    {
      "id": 195406,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-02",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 228290,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-02",
      "transaction_shares": "23638",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "74637"
    },
    {
      "id": 228293,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-02",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 263904,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-02",
      "transaction_shares": "23638",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "74637"
    },
    {
      "id": 263907,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-02",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 305172,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-02",
      "transaction_shares": "23638",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "74637"
    },
    {
      "id": 305175,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-02",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 110495,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1100.03",
      "transaction_type": "S",
      "shares_after_transaction": "17782"
    },
    {
      "id": 110509,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1053.22",
      "transaction_type": "S",
      "shares_after_transaction": "17881"
    },
    {
      "id": 110526,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-08-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 136645,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1100.03",
      "transaction_type": "S",
      "shares_after_transaction": "17782"
    },
    {
      "id": 136659,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1053.22",
      "transaction_type": "S",
      "shares_after_transaction": "17881"
    },
    {
      "id": 136680,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-08-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 164787,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1100.03",
      "transaction_type": "S",
      "shares_after_transaction": "17782"
    },
    {
      "id": 164803,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1053.22",
      "transaction_type": "S",
      "shares_after_transaction": "17881"
    },
    {
      "id": 164824,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-08-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 195390,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1100.03",
      "transaction_type": "S",
      "shares_after_transaction": "17782"
    },
    {
      "id": 195407,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1053.22",
      "transaction_type": "S",
      "shares_after_transaction": "17881"
    },
    {
      "id": 195428,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-08-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 228272,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1100.03",
      "transaction_type": "S",
      "shares_after_transaction": "17782"
    },
    {
      "id": 228294,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1053.22",
      "transaction_type": "S",
      "shares_after_transaction": "17881"
    },
    {
      "id": 228319,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-08-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 263885,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1100.03",
      "transaction_type": "S",
      "shares_after_transaction": "17782"
    },
    {
      "id": 263908,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1053.22",
      "transaction_type": "S",
      "shares_after_transaction": "17881"
    },
    {
      "id": 263935,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-08-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 305153,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1100.03",
      "transaction_type": "S",
      "shares_after_transaction": "17782"
    },
    {
      "id": 305176,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1053.22",
      "transaction_type": "S",
      "shares_after_transaction": "17881"
    },
    {
      "id": 305203,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-08-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 86304,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-07-11",
      "transaction_shares": "1866",
      "transaction_price": "1088.95",
      "transaction_type": "S",
      "shares_after_transaction": "37937"
    },
    {
      "id": 110536,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-07-11",
      "transaction_shares": "1866",
      "transaction_price": "1088.95",
      "transaction_type": "S",
      "shares_after_transaction": "37937"
    },
    {
      "id": 136690,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-07-11",
      "transaction_shares": "1866",
      "transaction_price": "1088.95",
      "transaction_type": "S",
      "shares_after_transaction": "37937"
    },
    {
      "id": 164834,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-07-11",
      "transaction_shares": "1866",
      "transaction_price": "1088.95",
      "transaction_type": "S",
      "shares_after_transaction": "37937"
    },
    {
      "id": 195438,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-07-11",
      "transaction_shares": "1866",
      "transaction_price": "1088.95",
      "transaction_type": "S",
      "shares_after_transaction": "37937"
    },
    {
      "id": 228331,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-07-11",
      "transaction_shares": "1866",
      "transaction_price": "1088.95",
      "transaction_type": "S",
      "shares_after_transaction": "37937"
    },
    {
      "id": 263950,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-07-11",
      "transaction_shares": "1866",
      "transaction_price": "1088.95",
      "transaction_type": "S",
      "shares_after_transaction": "37937"
    },
    {
      "id": 305218,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-07-11",
      "transaction_shares": "1866",
      "transaction_price": "1088.95",
      "transaction_type": "S",
      "shares_after_transaction": "37937"
    },
    {
      "id": 86280,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-07-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 86309,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-01",
      "transaction_shares": "3",
      "transaction_price": "1047.11",
      "transaction_type": "S",
      "shares_after_transaction": "17979"
    },
    {
      "id": 110505,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-07-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 110541,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-01",
      "transaction_shares": "3",
      "transaction_price": "1047.11",
      "transaction_type": "S",
      "shares_after_transaction": "17979"
    },
    {
      "id": 136655,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-07-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 136695,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-01",
      "transaction_shares": "3",
      "transaction_price": "1047.11",
      "transaction_type": "S",
      "shares_after_transaction": "17979"
    },
    {
      "id": 164799,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-07-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 164839,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-01",
      "transaction_shares": "3",
      "transaction_price": "1047.11",
      "transaction_type": "S",
      "shares_after_transaction": "17979"
    },
    {
      "id": 195402,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-07-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 195443,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-01",
      "transaction_shares": "3",
      "transaction_price": "1047.11",
      "transaction_type": "S",
      "shares_after_transaction": "17979"
    },
    {
      "id": 228289,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-07-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 228336,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-01",
      "transaction_shares": "3",
      "transaction_price": "1047.11",
      "transaction_type": "S",
      "shares_after_transaction": "17979"
    },
    {
      "id": 263902,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-07-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 263955,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-01",
      "transaction_shares": "3",
      "transaction_price": "1047.11",
      "transaction_type": "S",
      "shares_after_transaction": "17979"
    },
    {
      "id": 305170,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-07-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 305223,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-01",
      "transaction_shares": "3",
      "transaction_price": "1047.11",
      "transaction_type": "S",
      "shares_after_transaction": "17979"
    }
  ]
}